BUY SCIENTEX (SCI MK) R e t a i l M a r k e t M o n i t o r 18 December QFY15: Within Expectations. (Maintained) MONEY TALK
|
|
- Dale Jefferson
- 7 years ago
- Views:
Transcription
1 R e t a i l M a r k e t M o n i t o r 18 December 214 MONEY TALK SCIENTEX (SCI MK) 1QFY15: Within Expectations Scientex s 1QFY15 core net profit of RM35.5m was within our estimate. Both yoy and qoq top-lines saw growth due to the higher sales from both the manufacturing and property segments. However, margins have seen depression as the company lowered its selling price for consumer packaging PE blown films, as part of its strategy to capture larger market share. We are bullish on Scientex s long-term prospects as the company is in the midst of quadrupling its consumer packaging capacity, paving way for it to become a regional player in this business. Also, we like Scientex s property division which has a good mix of affordable and premium houses. Any near-term price weakness due to the weak market sentiment would be an opportunity to accumulate the share. Maintain BUY. Target price: RM8.4. 1QFY15 RESULTS Year to 31 Jul (RMm) 1QFY15 qoq % chg yoy % chg Turnover Manufacturing Property 11.8 (6.2) 46.5 EBITDA 52.2 (21.3) 6.4 Operating profit 41.5 (26.2) 5.6 Manufacturing 14.7 (21.8) (16.9) Property 32. (13.1) 44.6 Finance costs (1.9) (1.6) 18.9 Pre-Tax Profit 4.2 (28.3) 6.3 Tax (9.) PATAMI 3.3 (38.) 3.1 Core PATAMI 35.5 (23.1) 2.9 Margins (%) +/- ppt +/- ppt EBITDA 12.1 (3.9) (1.3) EBIT 9.6 (3.9) (1.1) PBT 9.3 (4.2) (1.) Net Profit 8.2 (2.9).2 Within expectations. Scientex posted 1QFY15 revenue of RM431m (+18.2% yoy, +3.8 qoq) and core net profit of RM35.5m (+2.9% yoy, -23.1% qoq), representing 22% and 19% of our and consensus FY15 forecasts, respectively. The results are within our expectations as we expect Scientex s new capacity for consumer packaging PE films would result in more prominent contribution in 2HFY15. KEY FINANCIALS Year to 31 Jul (RMm) F 216F 217F Net turnover 1,229 1,59 1,679 1,932 2,251 EBITDA Operating profit Net profit (rep./act.) Net profit (adj.) EPS (sen) PE P/B EV/EBITDA Dividend yield (%) Net margin (%) Net debt/(cash) to equity (%) Interest cover ROE (%) Consensus net profit UOBKH/Consensus Source: Scientex, Bloomberg, UOB Kay Hian BUY (Maintained) Share Price RM6.84 Target Price RM8.4 Upside +22.8% COMPANY DESCRIPTION Scientex is one of the largest industrial packaging companies in the world and a niche property developer in Southern Malaysia. It is currently expanding its consumer packaging segment. STOCK DATA GICS sector Materials Bloomberg ticker: SCI MK Shares issued (m): Market cap (RMm): Market cap (US$m): mth avg t over (US$m):.7 PRICE CHART (lcy) SCIENTEX BHD Scientex Bhd/FBMKLCI Index 1 Volume (m) (%) Dec 13 Feb 14 Apr 14 Jun 14 Aug 14 Oct 14 Dec 14 Source: Bloomberg ANALYST Malaysia Retail Research Team research@uobkayhian.com w w w. u t r a d e. c o m. m y 1
2 R e t a i l M a r k e t M o n i t o r 18 December 214 EBIT would have been higher if not for unrealised forex losses. In 1QFY15, Scientex recorded RM5.2m of unrealised forex losses due to its US dollar borrowings. Scientex s 1QFY15 EBIT would be RM46.7m, excluding the unrealised losses. Manufacturing: Healthy sales growth but dampened margins due to market penetration strategy. The manufacturing segment recorded a yoy 1.8% sales growth as a result of the commissioning of new capacity for consumer packaging PE blown films. However, we understand that the yoy and qoq margin erosion was mainly due the company s strategy to lower its selling price by 6-7% for PE films to capture larger market share. We believe the current scenario could persist in 2QFY15, but don t expect further margin depression from the current level. Property: Steady growth from existing projects. For the property segment, the strong yoy growth was mainly due to the recognition of Scientex s existing development projects as well as the inaugural contribution from Taman Scientex Senai s latest development. On a yoy basis, the margin is largely sustained but the slight qoq decrease in margin is due to the less favourable product mix during the quarter. Qoq higher effective tax rate. Also, Scientex s weaker qoq bottomline is partly due to an exceptionally low effective tax rate of 11% in 4Q (1QFY15 s 22%). STOCK IMPACT Estimating CAGR of 16.4% in -17. Despite compression in some margins during the quarter, we are bullish on the company s longer term prospects. We are expecting Scientex to deliver yoy net profit growth of 9-2% in FY15-17 to RM162m, RM192m and RM23m respectively, from s RM148m. The earnings drivers are: a) the RM3m capacity expansion in consumer packaging, b) full earnings potential from industrial stretch film capacity, and c) stable 1-15% annual earnings growth from the property segment. Targeting for two-thirds of FY15 property sales to come from affordable housing projects. Due to the government s various cooling measures on the property market, Scientex near term focus would be more on affordable houses, in which demand is expected to be resilient despite slower growth of the sector. Scientex s 1QFY15 unbilled sales stood at RM631m, (vs 4Q s RM538m) which could provide earnings visibility over the next 1-2 years. In 1QFY15, Scientex had five new launches which consists of a mixture of affordable and niche residential properties. On track for consumer packaging capacity expansion. Scientex is on track to emerge as the largest blown film manufacturer in Malaysia, after the completion of its PE films capacity installation by end-14. Meanwhile, the capacity for the new product, CPP film, is expected to be installed in 1H15 and targeted for commercial run by end-15. Dividend yields of % in FY Scientex has a 3% dividend payout policy and it has consistently paid out more than 3% of earnings over the last five years. We estimate Scientex will offer decent dividend yields of 3.2% and 3.8% for FY15 and FY16 respectively. EARNINGS REVISION/RISK We make no change to our earnings forecasts. VALUATION/RECOMMENDATION Maintain BUY with unchanged target price of RM8.4, assuming 12x FY16F PE for the manufacturing segment and 8x FY16F PE for the property segment. Our target price has an implied FY16F PE of 7.9x and provides an 23% upside from current share price level. We think that any near-term price weakness due to the weak market sentiment would be an opportunity for long-term investors to accumulate the share. REVENUE TREND BY SEGMENT 2,5 5 2, 1,5 1, 5 M anufacturing (LHS) Property (LHS) OPERATING PROFIT BY SEGMENT M anufacturing (LHS) Property (LHS) CORE NET PROFIT AND GROWTH Core Net Profit (LHS) DIVIDEND AND YIELD TRENDS (sen) (%) Dividend (LHS) Yield (RHS) w w w. u t r a d e. c o m. m y 2
3 R e t a i l M a r k e t M o n i t o r 18 December 214 Bloomberg Consensus Recommendation Buy Sell Hold Valuation Ratios 7/13 7/14 7/15E 7/16E 17/12/214 1% % % P/E Target Price 8.3 EV/EBIT Upside 21.3% EV/EBITDA P/S Income Statement 7/13 7/14 7/15E 7/16E P/B Revenue 1,229 1,59 1,824 2,45 Div Yield (%) Gross Income Operating Income Profitability Ratios % 7/13 7/14 7/15E 7/16E Pretax Income Gross Margin Net Income Adjusted* EBITDA Margin EPS Adjusted Operating Margin Dividends Per Share Profit Margin Payout Ratio (%) Return on Assets EBITDA Return on Equity Peer Comparison Ticker Market -----PE P/B----- Yield 17 Dec 14 Cap (RMm) FY13 FY13 (%) Daibochi DPP MK Tomypak Holdings TOMY MK BP Plastics Holding BPP MK n.a..9 n.a. n.a. SLP Resources SLPR MK n.a. n.a. n.a. n.a. Thong Guan Industries TGI MK Average Scientex SCI MK Technical View Scientex (SCI MK) Technical BUY on breakout with +1.2% potential upside Last price: RM6.84 Target price : RM7.19, RM7.54 Support : RM6.71 Stop-loss : RM6.69 Buy on a breakout with a target price of RM7.54 and a stop-loss below RM6.69. The Bullish Harami Pattern was spotted on the chart which indicates the share price may form a reversal movement to the upside. A buy order can be placed when the share price manages to break the highest level of Bullish Harami at RM6.91. Given the diminishing trading volume, we expect the selling pressure to have gradually eased as the share price forms a new high to the upside pattern. With an improving Stochastic bullish crossover and an uptick in RSI, the share price will likely continue to make a new high towards the immediate target at RM7.19 and RM7.54. Source: Bursa Station Professional Expected Timeframe: 3 weeks to 3 months w w w. u t r a d e. c o m. m y 3
4 R e t a i l M a r k e t M o n i t o r 18 December 214 Disclosures/Disclaimers This report is prepared and/or distributed by UOB Kay Hian Pte Ltd ( UOBKH ), which is a holder of a capital markets services licence and an exempt financial adviser in Singapore. This report is provided for information only and is not an offer or a solicitation to deal in securities or to enter into any legal relations, nor an advice or a recommendation with respect to such securities. This report is prepared for general circulation. It does not have regard to the specific investment objectives, financial situation and the particular needs of any recipient hereof. Advice should be sought from a financial adviser regarding the suitability of the investment product, taking into account the specific investment objectives, financial situation or particular needs of any person in receipt of the recommendation, before the person makes a commitment to purchase the investment product. This report is confidential. This report may not be published, circulated, reproduced or distributed in whole or in part by any recipient of this report to any other person without the prior written consent of UOBKH. This report is not intended for distribution, publication to or use by any person in any jurisdiction outside Singapore or any other jurisdiction as UOBKH may determine in its absolute discretion, where the distribution, publication or use of this report would be contrary to applicable law or would subject UOBKH and its connected persons (as defined in the Financial Advisers Act, Chapter 11 of Singapore) to any registration, licensing or other requirements within such jurisdiction. The information or views in the report ( Information ) has been obtained or derived from sources believed by UOBKH to be reliable. However, UOBKH makes no representation as to the accuracy or completeness of such sources or the Information and UOBKH accepts no liability whatsoever for any loss or damage arising from the use of or reliance on the Information. UOBKH and its connected persons may have issued other reports expressing views different from the Information and all views expressed in all reports of UOBKH and its connected persons are subject to change without notice. UOBKH reserves the right to act upon or use the Information at any time, including before its publication herein. Except as otherwise indicated below, (1) UOBKH, its connected persons and its officers, employees and representatives may, to the extent permitted by law, transact with, perform or provide broking, underwriting, corporate finance-related or other services for or solicit business from, the subject corporation(s) referred to in this report; (2) UOBKH, its connected persons and its officers, employees and representatives may also, to the extent permitted by law, transact with, perform or provide broking or other services for or solicit business from, other persons in respect of dealings in the securities referred to in this report or other investments related thereto; (3) the officers, employees and representatives of UOBKH may also serve on the board of directors or in trustee positions with the subject corporation(s) referred to in this report. (All of the foregoing is hereafter referred to as the Subject Business ); and (4) UOBKH may otherwise have an interest (including a proprietary interest) in the subject corporation(s) referred to in this report. As of the date of this report, no analyst responsible for any of the content in this report has any proprietary position or material interest in the securities of the corporation(s) which are referred to in the content they respectively author or are otherwise responsible for. Each research analyst of UOBKH who produced this report hereby certifies that (1) the views expressed in this report in any event accurately reflect his/her personal views about all of the subject corporation(s) and securities in this report; (2) the report was produced independently by him/her; (3) he/she does not carry out, whether for himself/herself or on behalf of UOBKH or any other person, any of the Subject Business involving any of the subject corporation(s) or securities referred to in this report; and (4) he/she has not received and will not receive any compensation that is directly or indirectly related or linked to the recommendations or views expressed in this report or to any sales, trading, dealing or corporate finance advisory services or transaction in respect of the securities in this report. However, the compensation received by each such research analyst is based upon various factors, including UOBKH s total revenues, a portion of which are generated from UOBKH s business of dealing in securities. IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSES Where the report is distributed in Singapore and contains research analyses or reports from a foreign research house, please note: (i) recipients of the analyses or reports are to contact UOBKH (and not the relevant foreign research house) in Singapore in respect of any matters arising from, or in connection with, the analysis or report; and (ii) to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, UOBKH accepts legal responsibility for the contents of the analyses or reports IMPORTANT DISCLOSURES FOR U.S. PERSONS This research report was prepared by UOBKH, a company authorized, as noted above, to engage in securities activities in Singapore. UOBKH is not a registered broker-dealer in the United States and, therefore, is not subject to U.S. rules regarding the preparation of research reports and the independence of research analysts. This research report is provided for distribution by UOBKH (whether directly or through its US registered broker dealer affiliate named below) to major U.S. institutional investors in reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the Exchange Act ). All US persons that w w w. u t r a d e. c o m. m y 4
5 R e t a i l M a r k e t M o n i t o r 18 December 214 receive this document by way of distribution from or which they regard as being from UOBKH by their acceptance thereof represent and agree that they are a major institutional investor and understand the risks involved in executing transactions in securities. Any U.S. recipient of this research report wishing to effect any transaction to buy or sell securities or related financial instruments based on the information provided in this research report should do so only through UOB Kay Hian (U.S.) Inc ( UOBKHUS ), a registered brokerdealer in the United States. Under no circumstances should any recipient of this research report effect any transaction to buy or sell securities or related financial instruments through UOBKH. UOBKHUS accepts responsibility for the contents of this research report, subject to the terms set out below, to the extent that it is delivered to and intended to be received by a U.S. person other than a major U.S. institutional investor. The analyst whose name appears in this research report is not registered or qualified as a research analyst with the Financial Industry Regulatory Authority ( FINRA ) and may not be an associated person of UOBKHUS and, therefore, may not be subject to applicable restrictions under FINRA Rules on communications with a subject company, public appearances and trading securities held by a research analyst account. Analyst Certification/Regulation AC As noted above, each research analyst of UOBKH who produced this report hereby certifies that (1) the views expressed in this report accurately reflect his/her personal views about all of the subject corporation(s) and securities in this report; (2) the report was produced independently by him/her; (3) he/she does not carry out, whether for himself/herself or on behalf of UOBKH or any other person, any of the Subject Business involving any of the subject corporation(s) or securities referred to in this report; and (4) he/she has not received and will not receive any compensation that is directly or indirectly related or linked to the recommendations or views expressed in this report or to any sales, trading, dealing or corporate finance advisory services or transaction in respect of the securities in this report. However, the compensation received by each such research analyst is based upon various factors, including UOBKH s total revenues, a portion of which are generated from UOBKH s business of dealing in securities. UOB Kay Hian (Malaysia) Holdings Sdn Bhd (2112-T) Suite 19-2, 19th Floor, Menara Keck Seng, 23 Jalan Bukit Bintang, 551 Kuala Lumpur, Malaysia. Tel: (63) , Fax: (63) MCI (P) 116/3/214 RCB Regn. No E Copyright 214, UOB Kay Hian Pte Ltd. All rights reserved. w w w. u t r a d e. c o m. m y 5
BUY (Upgraded) Del Monte Pacific (DELM SP) STRATEGY SINGAPORE. The Turnaround Is Here; Upgrade to BUY. Refer to last page for important disclosures.
STRATEGY SINGAPORE Del Monte Pacific (DELM SP) The Turnaround Is Here; Upgrade to BUY Net profit for 2QFY16 surged to US$53m from US$185,000 in 2QFY15. Recurring net income stood at US$18m, reflecting
More informationIn line performance. Results update 4Q2015. Banks UAE 28 January 2016 DUBAI ISLAMIC BANK
28 Jan 15 28 Apr 15 28 Jul 15 28 Oct 15 DUBAI ISLAMIC BANK In line performance Results update 4Q2015 Banks UAE 28 January 2016 Dubai Islamic Bank s (DIB) reported net profit of AED865mn, in-line with our
More informationKINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES
25 July 2014 2QFY14 Results Review Public Bank ROE likely to continue to trend lower moving forward INVESTMENT HIGHLIGHTS Modest growth in net income in 1HFY14 of 3.5%yoy. Group loan growth decent at 9.9%
More informationGujarat State Petronet Ltd. INR 135
Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 India Equity Institutional Research Oil & Gas RESULT UPDATE Gujarat State Petronet Ltd. INR 135 Growth in volumes to propel earnings Accumulate Gujarat
More informationSatisfactory Top-Line; Disappointing Bottom-Line
: Tsingtao Brewery (00168 HK) 公 司 报 告 : 青 岛 啤 酒 (00168 HK) Satisfactory Top-Line; Disappointing Bottom-Line 销 售 增 长 理 想 但 盈 利 能 力 令 人 失 望 Sunny Kwok 郭 日 升 +852 2509 2642 sunny.kwok@gtjas.com.hk GTJA Research
More informationBUY. Sona Petroleum (SONA MK) R e t a i l M a r k e t M o n i t o r Friday, 22 Ap ril 2016. Decent Chance Of Gains From Both Outcomes
MONEY TALK Sona Petroleum (SONA MK) Decent Chance Of Gains From Both Outcomes Sona will seek shareholders approval for the purchase of the Stag Oilfield (QA) on 26 April. If the QA is not approved, shareholders
More informationKingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3.
Equity Research Information Technology Aug 2, 21 Kingdee (28 HK) Buy (maintained) Target price: HK$.8 Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$.8 Lower-than-expected
More informationAxis Bank. Strong core performance. Source: Company Data; PL Research
Strong core performance January 17, 2011 Abhijit Majumder abhijitmajumder@plindia.com +91 22 66322236 Umang Shah umangshah@plindia.com +91 22 66322242 Rating BUY Price Rs1,230 Target Price Rs1,600 Implied
More informationCinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold
Equity Research Financials Cinda (111 HK) Hold (Initiation) Target price: HK$1.55 Facing intense competition from Chinese brokers in HK; initiate at Hold China Cinda s international business platform Cinda
More informationFlexituff International Ltd. (FIL)
s $CompanyN ame$ Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 (Wholly owned subsidiary of Bank of Baroda) Q2FY16 Result Review BUY Flexituff International Ltd. (FIL)
More informationHLIB Research PP 9484/12/2012 (031413)
Sunway (BUY, EPS ) INDUSTRY: OVERWEIGHT EARNINGS EVALUATION 2Q results: Decent rebound Results 1HFY12 core earnings grew by 7% to RM141.9m (10.98 sen/share) making up 42% ours and streets estimates respectively.
More informationSOHO CHINA (410.HK) At the Key Phase of Business Transformation. Neutral (Update) HONG KONG PROPERTY COMPANY UPDATE.
SOHO CHINA (410.HK) At the Key Phase of Business Transformation HONG KONG PROPERTY COMPANY UPDATE 26 August 2015 Summary Realized revenue of SOHO China dropped by 92% yoy to RMB393 million while realized
More informationPrivate drilling fluid technology service leader
21 March 2012 Equity Research Report Company Research Petroleum & Petrochemical Sichuan Renzhi Oilfield Technology Services (002629) Investment value analysis report Private drilling fluid technology service
More informationMphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research
FY17 could be a year of revenue growth February 08, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating Accumulate Price Rs440 Target Price Rs510 Implied Upside 15.9% Sensex 24,617 Nifty
More informationLoxley (Loxley TB) Trading Buy. No Surprises. Communications - Telecommunications Target Price: THB10.6 Market Cap: USD540m Price: THB7.
Results Review, Loxley (Loxley TB) Trading Buy Communications - Telecommunications Target Price: THB10.6 Market Cap: USD540m Price: THB7.65 No Surprises Macro Risks Growth Value Vol m 8.6 7.6 6.6 5.6 4.6
More informationBritannia Industries
Rally in Input costs near term drag, Maintain BUY June 20, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating BUY Price Rs2,641
More informationBDI BioEnergy Intern. 20.0 Neutral. Activity level in Q3 might not support FY estimates
8/11/1 8/1/11 8/3/11 8/5/11 8/7/11 8/9/11 8/11/11 8/1/12 8/3/12 8/5/12 8/7/12 8/9/12 MATELAN Research Preview Note Price as of 9/11/12: 8.69 12 November 212 Company / Sector Fair Value Recommendation BDI
More informationBUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value
UK Daily Letter 1 K3 Business Technology Group KBT : AIM : 144p BUY Target: 215p Bob Liao, CFA 44.20.7050.6654 bliao@canaccordgenuity.com COMPANY STATISTICS: 52-week Range: 0.82-1.50 Avg. Daily Vol. (000s):
More informationBright Smart (1428 HK)
Equity Research Financials Bright Smart (1428 ) Hold (initiation) Target price: $1.70 Local broker with high ROE; initiate at Hold Local broker with expansion ambition Bright Smart is a securities, commodities
More informationStrong operational performance
ABB India Equity Research Engineering & Capital Goods February 8, 2016 Result Update Emkay Your success is our success Strong operational performance CMP Target Price Rs1,134 Rs1,407 ( ) Rating Upside
More informationGlaxoSmithKline Consumer Healthcare
Strong pricing power, Attractive valuations "BUY" February 09, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating BUY Price Rs5,837
More informationThe Ramco Cements. Source: Company Data; PL Research
Robust performance; remains the best play on Southern region February 09, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY Price
More informationSimplex Infrastructures
2QFY216 Result Update Infrastructure November 17, 215 Simplex Infrastructures Performance Highlights Quarterly highlights - Standalone Y/E March (` cr) 2QFY16 1QFY16 2QFY15 % chg (yoy) % chg (qoq) Net
More informationHeng Huat Resources Group Berhad Fair Value: RM0.48 Making Its Mark
A Member of the TA Group MENARA TA ONE, 22 JALAN P. RAMLEE, 50250 KUALA LUMPUR, MALAYSIA TEL: +603-20721277 / FAX: +603-20325048 IPO Friday, July 11, 2014 FBM KLCI: 1,892.62 Sector: Automotive Heng Huat
More informationCompany Report. New China Life (1336 HK) Hold Life & Health Insurance Industry 2013E target price: HK$34.30 (from HK$24.
New China Life Company Report New China Life (1336 HK) Hold Life & Health Insurance Industry 2013E target price: HK$34.30 (from HK$24.85 previously) Key data H-share price (HK$) 31.45 Target price (HK$)
More informationGAIL (India) Ltd. INR 346
Feb-15 Apr-15 Jun-15 Aug-15 Oct-15 Dec-15 Feb-16 India Equity Institutional Research Oil & Gas RESULT UPDATE GAIL (India) Ltd. INR 346 Good performance; Near term outlook looks stable BUY GAIL reported
More informationSUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH
Q2FY16 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH SUPREME INDUSTRIES LTD Plastic Products BSE CODE:509930 NSE CODE: SUPREMEIND Bloomberg CODE: SIL IN SENSEX: 24,470 HOLD CMP Rs725
More informationWhen the going get tough...
When the going get tough... Fondsfinans Research Sparebank 1 SR Bank 2Q15 Update Recommendation: BUY Target NOK 62 13 August 2015 Prepared by Analyst: Geir Kristiansen, Fondsfinans AS, tel: 23 11 30 11,
More informationMorning Buzz NEWS BUZZ TODAY S HEADLINE. AmFraser Research Team www.amfraserdirect.com.sg
Morning Buzz Monday, 17 November 2014 STI INDEX (PREVIOUS DAY CLOSE) 3,315.67 (0.32%) Vol (mil): 1,735.4 / Val (S$ mil): 1,064.9 MAJOR STOCK INDICES Close % Chge DJ Ind Avg 17,634.74-0.10% S & P 500 2,039.82
More informationExhibit 1: Financial summary of First Tractor in 1H12-1H14 1H12 2H12 1H13 2H13 1H14 (% YoY)
Capital Goods Manufacturing ector August 29, 214 Company Report Rating: HOLD TP: HK$ 4.8 H-hare price (HK$) 5.17 Est. share price return (7.16%) Est. dividend yield 1.39% Est. total return (5.77%) First
More informationDATRON AG. Investor day supports our positive view. Buy (Buy) 12.50 EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015
BANKHAUS LAMPE // 1 DATRON AG Investor day supports our positive view 17/09/2015 Buy (Buy) 12.50 EUR (12.50 EUR ) Close 15/09/2015 9.75 EUR Bloomberg: DAR GY WKN: A0V9LA Sector Engineering Share price
More informationG5 Entertainment. G5 Entertainment. Quarter Update Q3 15. Amended strategy and boosted profitability
Quarter Update Q3 15 Last updated on the 18/11/2015 Share Price Market Capitalisation Target Price 41.00 SEK 360.8m SEK 49.05 SEK Amended strategy and boosted profitability reported their third quarter
More informationGraphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.
Sector Update Rating matrix Target price Company Old New CMP Potential Upside HEG 225 275 238 19% Graphite India 85 15 91 18% Target period 12-15 months Price performance (%) Return % 1M 3M 6M 12M HEG
More informationMangalam Cement Weak volumes marred performance
CMP* (Rs) 206 Market Cap. (Rs bn) 5.5 Free Float (%) 72 Shares O/S (mn) 26.7 Mangalam Cement Weak volumes marred performance Mangalam Cement (MCL) delivered a weak performance in 2Q but was marginally
More informationEmirates NBD (ENBD) Strong Buy. Target Price AED10.0. Global Research Investment Update Equity UAE Banking Sector 31 January, 2016
Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Global Research Investment Update Equity UAE Banking Sector 31 January, 2016 Market Data Bloomberg Code: Emirates
More informationPidilite Industries. Source: Company Data; PL Research
Bountiful margin expansion in a tepid demand scenario February 03, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating Accumulate
More informationPI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI
$Com panyname$ Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 2QFY16 Result Review (Wholly owned subsidiary of Bank of Baroda) HOLD PI Industries Ltd. Custom synthesis
More informationASEAN Weekly Wrap. Indonesia fiscal deficit revised higher to 2.35% of GDP. Economic Update
Indonesia fiscal deficit revised higher to 2.35% of GDP Thailand s imports unexpectedly rise, but exports declined Indonesia s revised budget has been approved by the Parliament, where the country s GDP
More informationCoal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015
17-Nov-14 17-Dec-14 17-Jan-15 17-Feb-15 17-Mar-15 17-Apr-15 17-May-15 17-Jun-15 17-Jul-15 17-Aug-15 17-Sep-15 17-Oct-15 Coal India Ltd. Subdued e-auction realization impacted profitability Coal India Ltd.
More informationAurobindo Pharma. Source: Company Data; PL Research
Earnings in line; Strong guidance for FY17E maintained February 10, 2016 Surajit Pal surajitpal@plindia.com +912266322259 Rating BUY Price Rs691 Target Price Rs943 Implied Upside 36.5% Sensex 23,759 Nifty
More informationMaruti Suzuki. Source: Company Data; PL Research
Q3 results subdued, Outlook remains good; BUY January 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs4,103 Target Price Rs4,844 Implied Upside 18.1% Sensex 24,470 Nifty
More informationRenminbi Depreciation and the Hong Kong Economy
Thomas Shik Acting Chief Economist thomasshik@hangseng.com Renminbi Depreciation and the Hong Kong Economy If the recent weakness of the renminbi persists, it is likely to have a positive direct impact
More informationQuant Picks United Breweries
October 6, 2015 Quant Picks United Breweries Research Analyst Amit Gupta amit.gup@icicisecurities.com Raj Deepak Singh rajdeepak.singh@icicisecurities.com Azeem Ahmad azeem.ahmad@icicisecurities.com i
More informationSundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold
HOLD Target price (INR) 452 Momentum in loans sustains, upgrade to Hold India Equity Research Financials January 30, 2013 Rating The higher than expected growth in the NII was driven by an improvement
More informationKotak Mahindra Bank Rs 685
India Equity Institutional Research BANKS RESULT UPDATE Kotak Mahindra Bank Rs 685 Smooth merger; benefits to accrue HOLD KMB s consolidated PAT for Q4FY15 stood at INR 9.5 that primarily on the back of
More information2010 2011 2012E 2013E 2014E
11 April 2012 Equity Research Report Company Research Construction Engineering Zhejiang Yasha Decoration (002375) Comments on 2011 annual results Rapid growth in results, while profit quality continued
More informationIncreasing estimates and PT on expectation of solid earnings momentum. Growth momentum and turnaround of insurance business
A cc or # $T ypcap$ 1628 1 0 4 2 Equity flash Trading Update Financial Services Hypoport AG BUY (BUY) Target 21.00 EUR (17.00 EUR) Price (last closing price) : 18.49 EUR Upside : 14% Est. change 2015e
More informationCompany Overview. Financial Performance
Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 SPS Finquest Ltd CMP: 84.60 January 13, 2015 Stock Details BSE code 538402 BSE ID SPS Face value ( ) 10 No of shares
More informationBharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research
Strong margins, improved inflows! January 28, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,228 Target Price Rs1,353
More informationKhambatta Securities Ltd.
Attractive Valuation Strong Buy Sector : Bank Private Target Price : Rs 284 Current Market Price : Rs 230 Market Cap : Rs 1,337 bn 52-week High/Low : Rs 393/216 Daily Avg. Volume : 13.88 mn Shares in issue
More informationEuropean Freight Forwarding Index
European Freight Forwarding Index 14 January 13 Erik Bergöö erbe@danskebank.dk +45 45 12 36 Søren Toft stof@danskebank.dk +45 45 12 53 Important disclosures and certifications are contained from page 12
More informationThree growth drivers amid high base for growth
14 Aug 2012 Equity Research Report Company Research Electronics Huizhou Speed Wireless Technology (300322) Investment value analysis report Three growth drivers amid high base for growth Investment Highlights
More informationHCC BUY. Infrastructure January 29, 2016
Jan-15 Mar-15 Apr-15 May-15 Jul-15 Aug-15 Sep-15 Nov-15 Dec-15 Jan-16 India Research Infrastructure January 29, 2016 QUARTERLY REVIEW Bloomberg: IN Reuters: HCNS.BO BUY Better margins drive earnings s
More informationMATELAN Research. Intelligent Transportation Systems MEGATRENDS DRIVE MARKET GROWTH FINANCIALS ACCELERATING IVU AND INIT SHOW HIGHEST UPSIDES
MATELAN Research Intelligent Transportation Systems MEGATRENDS DRIVE MARKET GROWTH FINANCIALS ACCELERATING IVU AND INIT SHOW HIGHEST UPSIDES 2/5/12 2/7/12 2/9/12 2/11/12 2/1/13 2/3/13 2/5/13 2/7/13 2/9/13
More informationINVESTMENT CASE FULLY INTACT
Leifheit AG Q2 results due out on 12/08/2015 07/08/2015 INVESTMENT CASE FULLY INTACT Buy 60.00 EUR Close (06/08/2015) 47.68 EUR Bloomberg: LEI WKN: 646450 Sector Share price performance Consumer 52 week
More informationCEWE Stiftung & Co. KGaA
CEWE Stiftung & Co. KGaA Solid development - on track to reaching targets 12/05/2015 Hold 60.00 EUR Close (11/05/2015) 57.81 EUR Bloomberg: CWC WKN: 540390 Sector Share price performance Consumer 52 week
More informationHOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights
05 FEB 2016 Quarterly Update HOLD Target Price: Rs 252 Q4 lackluster; CY16 holds promise Hexaware s Q4CY15 performance was lower than our estimates. Revenue growth and margin were largely impacted due
More informationQATAR NATIONAL BANK (QE: QNBK)
WEALTH MANAGEMENT Dominant market position in Qatar complemented by a growing regional presence in high growth, underpenetrated markets expected to drive future earnings growth for QNB. STOCK OF THE MONTH
More informationJubilant Life Sciences
Radiopharma, Niacin continues to drive sales, margins October 30, 2015 Surajit Pal surajitpal@plindia.com +912266322259 Rating BUY Price Rs401 Target Price Rs578 Implied Upside 44.1% Sensex 26,838 Nifty
More informationBUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights
05 FEB 2016 Quarterly Update BUY Target Price: Rs 344 Muted Q3; Brands & Retail story to unfold Arvind s Q3 consolidated revenue at Rs 21.6 bn (Rs 20.7 bn in Q3FY15) was marginally below our estimate of
More informationShriram Transport Finance Subsidiaries witness sharp increase in NPA
Shriram Transport Finance Subsidiaries witness sharp increase in NPA Shriram Transport Finance s (STFC) standalone performance was broadly in-line with our expectation but grossly disappointed on asset
More informationeuromicron AG Corrections to financial statements Hold 14.00 EUR
euromicron AG Corrections to financial statements 24/03/2015 Hold 14.00 EUR Close (23/03/2015) Bloomberg: EUCA Sector Share price performance 14.15 EUR WKN: A1K030 Technology 52 week high 14.18 52 week
More informationMinda Industries Ltd. INR 886
Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 India Equity Institutional Research Automobiles RESULT UPDATE Minda Industries Ltd. INR 886 Profit boosted by margins ACCUMULATE In Q3FY16, Minda Industries
More informationYear-end Dec 2013A 2014E 2015E 2016E Key data. # Priced at market close, 29/09/14
This research is intended for UK institutional investors only and market professionals. It is not intended for retail customers and any retail customer should seek professional, independent advice before
More informationChina Pacific (2601 HK) Unrated Life & health industry
21 August 2012 Equity Focus Key Data H-share price (HK$) 25.20 Target price (HK$) NA Upside potential (%) NA 52Wk H/L(HK$) 31.0 / 19.8 Issued shares: H-shares (mn) 2,313 A-shares (mn) 6,287 H-share mkt
More informationBata India Ltd. (BIL)
Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Q2FY16 Result Review (Wholly owned subsidiary of Bank of Baroda) BUY Bata India Ltd. (BIL) Cloudy quarter sunshine ahead;
More informationHOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights
The case of missing sales growth Zydus Q3 net sales at Rs1.1 bn was up 3% on a like-to-like basis (Q3 15 had Rs 223 mn additional excise duty credit from prior periods), below our estimate of 6%. The company
More informationU.S. EQUITIES: VALUATION & FUNDAMENTALS
LM Market Insight: U.S. EQUITIES: VALUATION & FUNDAMENTALS APR 2016 THIS MATERIAL IS ONLY FOR DISTRIBUTION IN THOSE COUNTRIES AND TO THOSE RECIPIENTS LISTED. PLEASE REFER TO THE DISCLOSURE INFORMATION
More informationEmkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins
HSIL India Equity Research Others February 3, 2016 Result Update Emkay Your success is our success Revenues traction improves; Retain BUY CMP Target Price Rs271 Rs370 ( ) Rating Upside BUY ( ) 36.6 % Healthy
More informationTough Quarters Ahead, Downgrade to Reduce
: Tsingtao Brewery (00168 HK) Sunny Kwok 郭 日 升 公 司 报 告 : 青 岛 啤 酒 (00168 HK) +852 2509 2642 sunny.kwok@gtjas.com.hk Tough Quarters Ahead, Downgrade to Reduce 未 来 数 季 情 况 更 严 峻, 下 调 至 减 持 GTJA Research 国
More informationTree House Education & Accessories
2QFY2016 Result Update Educational Services November 10, 2015 Tree House Education & Accessories Performance Highlights Y/E March (` cr) 2QFY16 2QFY15 % chg (qoq) 1QFY16 % chg (yoy) Net sales 57 50 15.1
More informationResults impacted by subdued demand
India Equity Research Agri Input & Chemicals January 25, 2016 Result Update Coromandel International Results impacted by subdued demand Emkay Your success is our success CMP Target Price Rs165 Rs225 (
More information1H15 Results Inline. Results Note. Price: RM1.01 Target Price: RM1.86. PP7004/02/2013(031762) Page 1 of 5. 21 August 2015
AirAsia Berhad 1H15 Results Inline By Adrian Ng l adrian.ng@kenanga.com.my Period 2Q15/1H15. Actual vs. Expectations AIRASIA s 1H15 core net profit of RM262m accounts for 41% both our and consensus fullyear
More informationVa Tech Wabag. Source: Company Data; PL Research
Weak execution, guidance hints a strong Q4FY16 February 08, 2016 Nishna Biyani nishnabiyani@plindia.com +91 22 66322239 Keyur Pandya keyurpandya@plindia.com +91 22 +91 22 66322247 Rating BUY Price Rs577
More informationPolaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, 2015. Target Price Rs220. IT India.
CMP* (Rs) 204 Market Cap. (Rs bn) 20 Free Float (%) 71 Shares O/S (mn) 100 Polaris Virtusa acquires majority in Polaris Virtusa Corp has purchased promoter and Citi s stake in Polaris of 53% for Rs220
More informationDeutsche Bank Global Transaction Banking. What DR investors are buying: An analysis of investment drivers for depositary receipts
What DR investors are buying: An analysis of investment drivers for depositary receipts What DR investors are buying: An analysis of investment drivers for depositary receipts Conventional methods of trying
More informationSK Networks (001740 KS)
Korea Research Earnings review Korea / Industrials 11 January 2013 HOLD Target price Last price (9 Jan 13) KRW9,000 KRW8,590 Upside/downside (%) 4.8 KOSPI 1997.94 Mkt. cap (KRWbn/US$bn) 2,132/2.0 52 week
More informationBackground information. Changes in the shareholder structure and balance sheet. Contract with Google prolonged for two years
A cc or # $T ypcap$ 1628 1 0 4 2 Page 1/5 Equity flash Newsflow Telecommunication HOLD (HOLD) Target EUR 4.00 (EUR 4.00) Price (last closing price) : EUR 2.84 Upside : 40 % Est. change 2015e 2016e EPS
More informationCompany Report. Ping An (2318 HK) Sell Life & Health Insurance Industry 2013E target price: HK$68.46 (from HK$58.04 previously)
Ping An Company Report Ping An (2318 HK) Sell Life & Health Insurance Industry 2013E target price: HK$68.46 (from HK$58.04 previously) Key data H-share price (HK$) 66.95 Target price (HK$) 68.46 Upside
More informationGreenply Industries Ltd
Change in Estimates Rating Target Greenply Industries Ltd Q2 FY16 Q2FY16 net revenue of Greenply Industries or GIL at Rs401cr, 2.5%/9.2% below our/bloomberg estimate of Rs411cr/Rs441cr, respectively, led
More informationLongfor (960 HK) Unrated Real Estate Development Industry
20 Septemper 2012 Equity Focus Key Data Share price (HK$) 11.78 52Wk H/L(HK$) 13.5/6.5 Issued shares (mn) 5,167.3 Market cap (HK$mn) 60,974 30-day avg vol (HK$mn) 137.14 Auditors Deloitte Major shareholder:
More informationTime to reap synergies
Time to reap synergies Fondsfinans Research Sparebank 1 Østfold-Akershus - 4Q14 Update Recommendation: BUY Target NOK 180 16 February 2015 Prepared by Analyst: Geir Kristiansen, Fondsfinans AS, tel: 23
More informationAccumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH
Q3FY16 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH Exide Industries Ltd(EIL) Automobile Ancillaries BSE CODE: 500086 NSE CODE: EXIDEIND Bloomberg CODE: EXID IN SENSEX: 23,759 Accumulate
More informationHOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers
05 FEB 2016 Quarterly Update HOLD Target Price: Rs 1,213 Q4 earnings beat but order backlog flat s Q4CY15revenue at Rs24bnwasin line withour expectation of Rs24bn. EBITDA margin improved 290 bps YoYand
More informationSalzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment
$CompanyN ame$ Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 2QFY16 Result Review (Wholly owned subsidiary of Bank of Baroda) BUY Salzer Electronics Ltd. Steady
More informationAmoreG (002790) BUY ( initiate ) Growth beyond Amorepacific? 2Q13 results met market consensus
KOREA August 7, 13 Company Earnings Review t AmoreG (79) BUY ( initiate ) Hyerim Kim Analyst Pharmaceuticals, Cosmetics 8--611-91 hyerim.kim@hdsrc.com Ernest Kim RA 8--611-957 ernest.kim@hdsrc.com Current
More informationBuy (Maintained) Hai-O (HAIO MK) Back On Track. Consumer Non-cyclical - Pharmaceuticals Target Price: MYR3.28 Market Cap: USD166m Price: MYR2.
Jul-12 Sep-12 Nov-12 Jan-13 Mar-13 May-13 Vol m Company Update, 23 July 213 Hai-O (HAIO MK) Buy (Maintained) Consumer Non-cyclical - Pharmaceuticals Target Price: MYR3.28 Market Cap: USD166m Price: MYR2.68
More informationBurcon NutraScience Corp.
OUTTHINK OUTPERFORM REPEAT OFTEN The best ideas are the ideas that make clients money. That s why Paradigm Capital approaches every investment opportunity with calculated boldness and fresh perspectives,
More informationThe Merchant Securities FTSE 100. Hindsight II Note PRIVATE CLIENT ADVISORY
The Merchant Securities FTSE 100 Hindsight II Note Our first FTSE-100 Hindsight Note is now fully subscribed; however, as a result of exceptional investor demand we are launching the FTSE- 100 Hindsight
More informationFIRST CAPITAL. Sound 2014 results and attractive dividend. Buy (maintained) Company Update
FIRST CAPITAL Company Update Buy (maintained) MARKET PRICE: EUR1.03 TARGET PRICE: EUR1.28 (from EUR1.15) Financial Holding Data Shares Outstanding (m): 24.04 Market Cap. (EURm): 24.77 NAV (EURm): 34.1
More informationAoyuan (3883 HK) Site visit to Guangzhou: Key takeaways
China Real Estates March 10, 2014 Company Report Rating: BUY TP: HK$ 2.20 Ke Share price (HK$) 1.48 Est. share price return 48.6% Est. dividend yield 4.3% Est. total return 52.9% Previous Rating &TP Key
More informationShare gains with healthy margin uptick; Retain Buy
Colgate-Palmolive India Equity Research Consumers January 23, 2015 Result Update Emkay Your success is our success Share gains with healthy margin uptick; Retain Buy CMP Target Price Rs1,913 Rs1,940 (
More informationGladiator Stocks: Phillips Carbon Black (PHICAR) Time Frame: Six months
Gladiator Stocks: Phillips Carbon Black (PHICAR) Time Frame: Six months CMP: 160.00 00 Buying Range: 155.00-160.00 160 Target: 196.00 Stop loss: 137.00 Upside: 25% Stock Data 52 Week High / Low 162.95/80
More informationLarsen & Toubro. Source: Company Data; PL Research
Order inflow surprise, challenges on profitability continues! January 29, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating BUY Price Rs1,102
More informationRAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16
RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS Earnings Presentation Q2 FY16 Company Overview COMPANY OVERVIEW Rajesh Exports Ltd. (REL) was incorporated in 1989. Currently REL is a leader
More informationDr. Reddy's Laboratories
Result in line; Tepid guidance for Q4FY16 on weak EM, currency February 10, 2016 Surajit Pal surajitpal@plindia.com +912266322259 Rating Accumulate Price Rs2,960 Target Price Rs3,083 Implied Upside 4.2%
More informationBDI BioEnergy Internat. 14.5 Buy
20/08/13 20/10/13 20/12/13 20/02/14 20/04/14 20/06/14 20/08/14 20/10/14 20/12/14 20/02/15 20/04/15 20/06/15 MATELAN Research Update Note Price as of 20/08/15: 10.80 21 August 2015 Company / Sector Fair
More informationPEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)
BUY CMP 196.40 Target Price 225.00 STYLAM INDUSTRIES LIMITED Result Update (PARENT BASIS): Q2 FY16 DECEMBER 16 th. 2015 ISIN: INE239C01012 12 th h, 2013 Index Details Stock Data Sector Plastic Products
More informationResearch Commodities El Niño returns grains and soft commodities at risk
Investment Research General Market Conditions 20 May 2015 Research Commodities El Niño returns grains and soft commodities at risk Meteorologists now agree that El Niño has arrived and project that it
More informationOptimizeRx OPRX. Buy. Platform Potential Continues to Grow $0.87 $4.00. Refer to the last two pages of this report for Disclosures
Nov 14, 2014 Healthcare OptimizeRx Platform Potential Continues to Grow Other OTC OPRX Buy Rating Unchanged Current Price $0.87 Target Price $4.00 Market Capitalization 20.32M Shares Outstanding 23.36M
More information